Analytical Laboratory AL-Luhnstedt, Bahnhofstraße 1, 24816 Luhnstedt, Germany.
UFZ Department of Ecological Chemistry, Helmholtz Centre for Environmental Research, Permoserstr. 15, 04318 Leipzig, Germany.
Sci Total Environ. 2018 Mar;616-617:97-106. doi: 10.1016/j.scitotenv.2017.10.317. Epub 2017 Nov 4.
Aquatic bioconcentration factors (BCFs) are critical in PBT (persistent, bioaccumulative, toxic) and risk assessment of chemicals. High costs and use of more than 100 fish per standard BCF study (OECD 305) call for alternative methods to replace as much in vivo testing as possible. The BCF waiving scheme is a screening tool combining QSAR classifications based on physicochemical properties related to the distribution (hydrophobicity, ionisation), persistence (biodegradability, hydrolysis), solubility and volatility (Henry's law constant) of substances in water bodies and aquatic biota to predict substances with low aquatic bioaccumulation (nonB, BCF<2000). The BCF waiving scheme was developed with a dataset of reliable BCFs for 998 compounds and externally validated with another 181 substances. It performs with 100% sensitivity (no false negatives), >50% efficacy (waiving potential), and complies with the OECD principles for valid QSARs. The chemical applicability domain of the BCF waiving scheme is given by the structures of the training set, with some compound classes explicitly excluded like organometallics, poly- and perfluorinated compounds, aromatic triphenylphosphates, surfactants. The prediction confidence of the BCF waiving scheme is based on applicability domain compliance, consensus modelling, and the structural similarity with known nonB and B/vB substances. Compounds classified as nonB by the BCF waiving scheme are candidates for waiving of BCF in vivo testing on fish due to low concern with regard to the B criterion. The BCF waiving scheme supports the 3Rs with a possible reduction of >50% of BCF in vivo testing on fish. If the target chemical is outside the applicability domain of the BCF waiving scheme or not classified as nonB, further assessments with in silico, in vitro or in vivo methods are necessary to either confirm or reject bioaccumulative behaviour.
水生生物浓缩因子(BCF)在持久性、生物累积性、毒性(PBT)物质和化学品风险评估中至关重要。由于 OECD305 标准 BCF 研究(需要使用超过 100 条鱼进行)的高成本和高要求,因此需要替代方法尽可能多地替代体内测试。BCF 豁免方案是一种筛选工具,它结合了基于与物质在水体和水生生物中分布(疏水性、离解度)、持久性(生物降解性、水解)、溶解性和挥发性(亨利定律常数)相关的理化性质的 QSAR 分类,以预测具有低水生生物累积性的物质(非 B,BCF<2000)。BCF 豁免方案是使用 998 种化合物的可靠 BCF 数据集开发的,并使用另外 181 种物质进行了外部验证。它具有 100%的灵敏度(无假阴性)、>50%的效能(豁免潜力),并且符合 OECD 有效 QSAR 的原则。BCF 豁免方案的化学适用性域由训练集的结构给出,一些化合物类别被明确排除,如有机金属化合物、多氟和全氟化合物、芳香三苯基磷酸盐、表面活性剂。BCF 豁免方案的预测置信度基于适用性域合规性、共识建模以及与已知非 B 和 B/vB 物质的结构相似性。通过 BCF 豁免方案分类为非 B 的化合物由于对 B 标准的关注较低,因此是豁免鱼类体内 BCF 测试的候选物质。BCF 豁免方案支持 3R 原则,可能减少>50%的鱼类体内 BCF 测试。如果目标化学物质不在 BCF 豁免方案的适用性域内或未被分类为非 B,则需要使用体外、体内或计算方法进行进一步评估,以确认或拒绝生物累积行为。